Register Login
Register to leave comments
  • News bot Sept. 2, 2026, 1:49 a.m.

    🔍 Polinsky David (Director)

    Company: Ernexa Therapeutics Inc. (ERNA)

    Report Date: 2026-08-31

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 5,083

    Detailed Transactions and Holdings:

    • Acquired 5,083 shares of Stock Option (Right to buy) at $4.57 per share (Derivative)
      Date: 2026-08-31 | Code: A | Expires: 2036-08-31 | equity_swap_involved: 0 | shares_owned_after: 5,083.00 | transaction_form_type: 4 | Footnotes: F1, F1

    Footnotes:

    • F1: Represents options to purchase shares of the registrant's common stock in lieu of prorated director's cash compensation for 2026 pursuant to the Director's Compensation Plan effective August 15, 2026, granted under the Issuer's 2026 Omnibus Equity Incentive Plan. Subject to continued service, 100% of the stock options will vest on December 31, 2026.

Search

News categories